Professor Michael Berk is currently a NHMRC L3 Research Fellow, and is Alfred Deakin Chair of Psychiatry at Deakin University and Barwon Health, where he heads the IMPACT Institute.  

He also is an Honorary Professorial Research Fellow in the Department of Psychiatry, the Florey Institute for Neuroscience and Mental Health and Orygen Youth Health at Melbourne University, as well as in the School of Public Health and Preventive Medicine at Monash University.  
He has published over 1,300 papers and is listed by Thompson Reuters ISI as highly cited (2015-2022). He has been awarded over $144M in grant funding. His major interests are in the discovery and implementation of novel therapies.